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 Abstract: Highly enantiomerically enriched γ- and δ-lactams have been prepared by a simple and very 
efficient procedure that involves the asymmetric transfer hydrogenation of N-(tert-
butylsulfinyl)iminoesters followed by desulfinylation of the nitrogen atom and spontaneous cyclization 
to the desired lactams during the basic work-up procedure. Five- and six-membered ring lactams 
bearing aromatic, heteroaromatic and aliphatic substituents have been obtained in very high yields and 
ee’s up to > 99%. A slight modification of the procedure also allowed the preparation of ε-lactams in 
good yields and very high enantioselectivities. Both enantiomers of the final lactams could be prepared 
with equal efficiency by changing the absolute configuration of the sulfinyl chiral auxiliary. 
 
Keywords: lactams; asymmetric transfer hydrogenation; ATH; iminoester; N-sulfinylimines; ruthenium 
catalyst; isopropyl alcohol. 
 
Introduction 
Chiral lactams occupy a remarkable position among the nitrogen heterocycles because they have 
shown to possess important biological activities and have found interesting applications in medicinal 
chemistry and pharmacology.1 Lactams display antitumor activities,2 operate as inhibitors of a variety of 
biochemical processes,3 and act as high performance antibiotics.4 Enantiomerically pure lactams have 
also been used as chiral ligands in asymmetric synthesis.5 For all of these reasons, the synthesis of 
optically enriched lactams has aroused the interest of several research groups.6 One of the most direct 
methods for the asymmetric synthesis of lactams is the cyclization of aminoesters, which can be 
prepared from the corresponding iminoesters through addition of nucleophiles to the imino group7 or 
selective reduction of the C=N bond.8 Among the iminoesters, the ones bearing a tert-butylsulfinyl 
group bonded to the nitrogen atom are very interesting starting materials for the asymmetric synthesis of 
enantiomerically enriched aminoesters. The tert-butylsulfinyl group has proved to be an excellent chiral 
auxiliary, showing high levels of asymmetric induction in a variety of processes.9 Moreover, it presents 
the advantage to be easily removable under mild acidic conditions.10 However, only a few examples of 
the use of N-(tert-butylsulfinyl)iminoesters as substrates for the asymmetric synthesis of chiral lactams 
can be found in the literature.7,8b,d  
In the last years, our research group has been studying the use of enantiomerically pure N-(tert-
butylsulfinyl)imines as substrates for diastereoselective transformations. Thus, we have performed their 
diastereoselective alkylation with organozinc reagents,11 allylation using indium metal12 and reaction 
with functionalized nucleophiles.13 In addition, we have recently developed the synthesis of highly 
optically enriched amines by asymmetric transfer hydrogenation (ATH) of N-(tert-
butylsulfinyl)ketimines.14,15 Employing a ruthenium catalyst bearing the achiral 2-amino-2-
methylpropan-1-ol as a ligand and isopropyl alcohol as the hydrogen source, we have been able to 
prepare a variety of aromatic and aliphatic chiral primary amines with very high enantiomeric purities 
and we have also studied the reaction mechanism.14c,d Herein we describe the use of the ATH of N-(tert-
butylsulfinyl)iminoesters as a key step to achieve the synthesis of different highly enantiomerically 
enriched γ-, δ- and ε-lactams. 
 
Results and Discussion 
The ATH is a reduction methodology which is very useful from a synthetic point of view because it 
allows the selective reduction of ketones or imines in the presence of ester moieties.16 We aimed to find 
an effective method for the asymmetric synthesis of lactams 4 (Scheme 1) and, according to our 
experience in the ATH of sulfinylimines, we thought that we could take advantage of the 
chemoselectivity indicated above and try to perform the selective reduction of the C=N bond of N-(tert-
butylsulfinyl)iminoesters 2 by using our ATH protocol, to obtain the protected aminoesters 3, which 
could be converted to the desired lactams by deprotection of the nitrogen atom and subsequent 
cyclization by intramolecular nucleophilic substitution on the ester moiety. 
 Scheme 1. Synthetic Plan for the Preparation of Chiral Lactams 4 
 
 
The starting point of our proposed synthetic route are ketoesters 1 (Scheme 1). Therefore, our first 
goal was the preparation of those starting materials. Chart 1 shows all the ketoesters that we have used. 
Some of them (1a, 1b, 1e and 1g) were commercially available. Compounds 1d, 1f and 1h-1k were 
easily prepared in 85-93% overall yields by iron-catalyzed addition of the corresponding Grignard 
reagents to succinic or glutaric anhydride (Scheme 2; n = 1 or 2, respectively),17 followed by standard 
esterification of the crude ketoacids. Compounds 1c and 1l were prepared in 97 and 98% yield, 
respectively, from the corresponding commercially available ketoacids as indicated in Scheme 2. 
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 Scheme 2. Synthesis of Ketoesters 1d, 1f and 1h-1k 
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Next, the required iminoesters were prepared by reaction of ketoesters 1 with either (R)- or (S)-2-
methylpropane-2-sulfinamide in the presence of titanium tetraethoxide under neat conditions (Scheme 
3), according to a procedure recently reported by us.18 Thus, the expected enantiomerically pure N-(tert-
butylsulfinyl)iminoesters with (R) (compounds 2) or (S) (compounds ent-2) absolute configuration were 
isolated in good yields after column chromatography. 
 
Scheme 3. Preparation of the Iminoesters 2 and ent-2a 
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a In brackets, isolated yield after column chromatography (silica gel, hexane/ethyl acetate) based on the starting 
ketoester 1. All isolated compounds 2 and ent-2 were ≥ 95% pure (300 MHz 1H NMR). 
 
Once we had prepared the desired sulfinyl iminoesters, we tried to reduce them using our ATH 
protocol. Iminoester 2a was chosen as a model substrate and our optimized conditions for the reduction 
of N-(tert-butylsulfinyl)ketimines14c,d were tried for its reduction. Gratifyingly, the hydrogen transfer to 
compound 2a from isopropyl alcohol catalyzed by a ruthenium complex bearing the achiral ligand 2-
amino-2-methylpropan-1-ol led to a selective reduction of the imine functionality in a short reaction 
time (2 h). No evidence for a possible reduction of the ester moiety could be observed in the 1H NMR 
spectrum of the reaction mixture. The crude protected aminoester was treated with a solution of HCl in 
MeOH in order to remove the sulfinyl group from the nitrogen atom. After performing a basic 
extraction process, lactam 4a was obtained as the only reaction product in 93% yield (Scheme 4). Thus, 
the initially formed deprotected aminoester spontaneously cyclizes during the basic work-up procedure 
through an intramolecular nucleophilic substitution reaction on the ester functionality by the free amino 
group.19 Therefore, a separate cyclization step was not needed. Noteworthy, the obtained lactam 4a was 
pure according to the 1H NMR spectrum, making any purification process unnecessary. Analysis of 4a 
by HPLC gave a 96% ee, the (R) enantiomer being the major one. 
Next, we studied the reaction scope by applying the same protocol to the other γ-iminoesters 2b-2f. 
The corresponding lactams 4b-4f were also obtained in very high yields and enantioselectivities 
(Scheme 4). The procedure worked with equal efficiency for the synthesis of γ-lactams bearing R 
groups which could be aromatic [substituted with either electron-releasing (4b) or electron-withdrawing 
groups (4c)] or aliphatic (4d-4f). When our ATH procedure was applied to the reduction of the aliphatic 
iminoesters 2d-2f, the catalyst loading had to be increased, as previously described by us.14c,d,20 
 
Scheme 4. Asymmetric Transfer Hydrogenation of N-(tert-butylsulfinyl)iminoesters 2 and ent-2. 
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a In brackets, isolated yield (based on the starting iminoester 2 or ent-2) and enantiomeric excess (determined by 
HPLC using a chiral column). All isolated compounds 4 and ent-4 were ≥ 95% pure (300 MHz 1H NMR). 
b [RuCl2(p-cymene)]2 (5 mol%), 2-amino-2-methylpropan-1-ol (10 mol%) and t-BuOK (25 mol%) were used in this 
reaction. 
c The ATH reaction crude was successively treated with 2 M HCl in MeOH/Et2O and then with MeONa to afford the 
lactam. Isolated yields of lactams 4l and ent-4l are given after column chromatography (silica gel, hexane/ethyl 
acetate). 
 
Encouraged by the good results obtained, we tried to extend our methodology to the preparation of δ- 
and ε-lactams from the corresponding N-(tert-butylsulfinyl)iminoesters 2g-2l (Scheme 3). We were 
delighted to see that δ-lactams bearing several aromatic (4g-4i) and heteroaromatic (4j) substituents 
were also obtained in pure form in excellent yields and enantiomeric excesses (Scheme 4). Noteworthy, 
a highly optically enriched (ee > 99%) aliphatic δ-lactam 4k could also be prepared in 95% yield.20 
However, when the synthesis of the 7-membered ring lactam 4l (Scheme 4) from iminoester 2l was 
attempted using the same procedure, the corresponding free aminoester was isolated after the final basic 
extraction process instead of the expected lactam. Fortunately, the desired ε-lactam 4l could be prepared 
in good yield and excellent enantiomeric excess by a slight modification of the experimental procedure: 
when the desulfinylation of the ATH product was complete, a freshly prepared solution of MeONa in 
MeOH was added and the mixture was stirred overnight. Thus, this modified procedure allowed us to 
extend the substrate scope to ε-iminoesters. 
Our methodology is equally efficient for the synthesis of both enantiomers of the final lactams. As 
expected, when imino esters ent-2, bearing the (S)-N-(tert-butylsulfinyl) chiral auxiliary, were used as 
substrates, the (S)-lactams ent-4 were obtained with yields and enantiomeric excesses which are almost 
identical to the ones observed in the corresponding (R)-lactams 4 (compare the corresponding 
enantiomeric products in Scheme 4). 
 
Conclusion 
We have presented here a simple, versatile and very effective procedure for the synthesis of highly 
optically enriched γ-, δ- and ε-lactams by application of our ATH protocol to the highly 
diastereoselective reduction of N-(tert-butylsulfinyl)iminoesters. The fact that chiral lactams bearing 
aromatic, heteroaromatic or aliphatic substituents can be prepared in similar and very high yields and 
enantiomeric excesses is a remarkable feature of our methodology. The absolute configuration of the 
final lactam can be tuned up simply by choosing the proper configuration on the sulfur atom of the 
sulfinyl moiety of the iminoester. To the best of our knowledge, the preparation of chiral lactams 
through metal-catalyzed ATH processes had not been described so far. 
 
Experimental Section 
General Information 
All glassware was dried in an oven at 100 ºC and cooled to room temperature under argon before use. 
All reactions were carried out under an argon atmosphere. Ketoesters 1a, 1b, 1e and 1g, (R)- and (S)-t-
BuSONH2, Ti(OEt)4 (33% TiO2 min), [RuCl2(p-cymene)]2, 2-amino-2-methylpropan-1-ol and all the 
starting materials needed for the synthesis of ketoesters 1c, 1d, 1f, and 1h-1l were commercially 
available and were used as received. t-BuOK was heated in a Kugel-Rohr distillation apparatus at 170-
180 °C under vacuum for 4 h before use. Commercially available 4 Å molecular sieves were dried in a 
Kugel-Rohr distillation apparatus at 120 ºC under vacuum for 5h before use. Commercially available 
anhydrous isopropyl alcohol was used as solvent in all the transfer hydrogenation reactions. Column 
chromatography was performed with silica gel 60 of 230–400 mesh. Thin layer chromatography (TLC) 
was performed on precoated silica gel plates; detection was done by UV254 light and staining with 
phosphomolybdic acid (solution of 1 g of phosphomolybdic acid in 24 mL of absolute ethanol); Rf 
values are given under these conditions. Melting points (mp) are uncorrected. Unless otherwise stated, 
NMR samples were prepared using CDCl3 as solvent. The internal references used for NMR spectra 
were tetramethylsilane (TMS) for 1H NMR and CDCl3 for 13C NMR; chemical shifts are given in δ 
(ppm) and coupling constants (J) in Hz. 13C NMR assignments were made on the basis of DEPT 
experiments. Infrared (FT-IR) spectra were obtained on a spectrophotometer equipped with an 
attenuated total reflectance (ATR) accessory. Mass spectra (EI) were obtained at 70 eV; fragment ions 
in m/z with relative intensities (%) in parenthesis are given. HRMS were measured with electron impact 
(EI) ionization at 70 eV and a double focusing mass analyzer (magnetic and electric fields). Optical 
rotation measurements and HPLC analyses were performed at 20 ºC. 
 
Synthesis of Ketoesters 1c, 1d, 1f, and 1h-1l. General Procedure 
A round-bottomed flask was charged with succinic anhydride (for compounds 1d and 1f) or glutaric 
anhydride (for compounds 1h-1k) (10.0 mmol), Fe(acac)3 (106 mg, 0.3 mmol) and anhydrous THF (12 
mL) and it was cooled down to 0 ºC. A solution of the corresponding Grignard reagent21 (8.3 mmol) 
was added over a period of 45 minutes with the aid of a syringe pump and the reaction was stirred 
overnight at the same temperature. Then, the mixture was acidified with a 2 M aqueous HCl solution 
(40 mL) and extracted with Et2O (3 × 20 mL). The combined organic phases were extracted with a 1 M 
aqueous NaOH solution (3 × 15 mL), discarding the organic layer. The combined aqueous basic phases 
were acidified with a 2 M aqueous HCl solution in order to obtain a pH around 1, and this mixture was 
extracted with Et2O (3 × 20 mL). The combined organic phases were dried (Na2SO4). After filtration 
and evaporation of the solvent, the expected ketoacids were obtained, which were used in the next step 
without purification. 
The obtained ketoacid (7.0 mmol) was dissolved in EtOH (40 mL), concentrated H2SO4 (1.1 mL, 21.0 
mmol) was added at room temperature and then, the reaction mixture was refluxed overnight. After 
evaporation of the solvent, H2O (10 mL) was added and the mixture was neutralized with a 2 M aqueous 
NaOH solution and extracted with Et2O (3 × 15 mL). The combined organic phases were dried 
(Na2SO4). After filtration and evaporation of the solvent, the expected ketoesters 1d (1.249 g, 90%), 1f 
(1.121 g, 93%), 1h (1.559 g, 89%), 1i (1.665 g, 88%), 1j (1.457 g, 92%) and 1k (1.108 g, 85%) were 
obtained in pure form. The same esterification procedure was also used for the preparation of ketoesters 
1c (1.634 g, 97%) and 1l (1.607 g, 98%) from the corresponding commercially available ketoacids. 
Ketoesters 1c,22 1f,23 1h,24 1j,25 1k26 and 1l27 were identified by comparison of their physical and 
spectroscopic data with the ones reported in the literature. The corresponding physical and spectroscopic 
data for compounds 1d and 1i follow. 
 
Ethyl 4-(cyclopentyl)-4-oxobutanoate (1d): yellowish oil; Rf 0.76 (hexane/ethyl acetate: 3/1); IR 
(neat) 1733, 1710, 1174 cm-1; 1H NMR (400 MHz, CDCl3) δ 1.25 (3H, t, J = 7.1 Hz), 1.53-1.70, 1.73-
1.88 (4H each, 2 m), 2.58 (2H, t, J = 6.6 Hz), 2.77 (2H, t, J = 6.6 Hz), 2.91 (1H, quintet, J = 7.8 Hz), 
4.13 (2H, q, J = 7.1 Hz); 13C NMR (100 MHz, CDCl3) δ 14.1, 25.9, 28.0, 28.8, 36.1, 51.2, 60.5, 172.9, 
211.1; m/z 198 (M+, 4%), 153 (27), 129 (50), 111 (18), 101 (77), 69 (100); HRMS: M+ found 198.1259, 
C11H18O3 requires 198.1256. 
 
Ethyl 5-(2-naphthyl)-5-oxopentanoate (1i): yellow solid; mp 63 ºC; Rf 0.57 (hexane/ethyl acetate: 
3/1); IR (KBr) 3056, 1731, 1688, 1185 cm-1; 1H-RMN (400 MHz, CDCl3) δ 1.24 (3H, t, J = 7.1 Hz), 
2.09-2.17 (2H, quintet, J = 7.2 Hz), 2.47 (2H, t, J = 7.2 Hz), 3.19 (2H, t, J = 7.2 Hz), 4.14 (2H, q, J = 
7.1 Hz), 7.47-7.61 (2H, m), 7.88 (2H, t, J = 7.8 Hz), 7.96 (1H, d, J = 7.8 Hz), 8.03 (1H, dd, J = 8.6, 1.7 
Hz), 8.48 (1H, s); 13C-RMN (100 MHz, CDCl3) δ 14.2, 19.5, 33.3, 37.5, 60.3, 123.7, 126.7, 127.7, 
128.4, 129.5, 129.6, 132.4, 134.1, 135.5, 172.9, 199.3; m/z 270 (M+, 18%), 225 (12), 156 (12), 155 
(100), 127 (41); HRMS: M+ found 270.1260, C17H18O3 requires 270.1256. 
 
Synthesis of Iminoesters 2 and ent-2. General Procedure 
N-(tert-Butylsulfinyl)iminoesters 2 and ent-2 were prepared by reaction of (R)-2-methylpropane-2-
sulfinamide (for 2) or (S)-2-methylpropane-2-sulfinamide (for ent-2) with the corresponding ketoester 
according to our recently reported procedure,18 as follows: the mixture of ketoester 1 (5.0 mmol), (R)- or 
(S)-t-BuSONH2 (612 mg, 5.0 mmol) and Ti(OEt)4 (2.1 mL, 10.0 mmol) was stirred overnight under 
argon at 72 ºC (oil bath temperature). After cooling to room temperature, the mixture was diluted with 
ethyl acetate (10 mL) and poured into brine (3 mL) while rapidly stirring. The resulting suspension was 
filtered through a plug of celite and the filter cake was washed with ethyl acetate. After evaporation of 
the solvent, the resulting residue was purified by column chromatography (silica gel, hexane/ethyl 
acetate), to give the expected products 2 and ent-2 in the yields indicated in Scheme 3. The 
corresponding physical, spectroscopic and analytical data for the obtained iminoesters follow. 
 
Ethyl 4-[(R)-tert-butylsulfinylimino]-4-phenylbutanoate (2a): yellow oil; Rf 0.35 (hexane/ethyl 
acetate: 7/3); [α]D20 −6.0 (c 2.4, CH2Cl2); IR (neat) 3062, 1732, 1604, 1595, 1181, 1074 cm-1; 1H NMR 
(300 MHz, CDCl3) δ 1.24 (3H, t, J = 7.0 Hz), 1.33 (9H, s), 2.50-2.94 (2H, m), 3.01-3.72 (2H, m), 4.12 
(2H, q, J = 7.0 Hz), 7.37-7.54 (3H, m), 7.75-7.90 (2H, m); 13C NMR (75 MHz, CDCl3) δ 14.2, 22.7, 
27.6, 32.9, 57.8, 60.8, 127.4, 128.7, 131.7, 137.2, 171.8, 177.7; m/z (DIP) 309 (M+, <1%), 253 (37), 207 
(51), 206 (12), 205 (95), 162 (19), 160 (18), 159 (14), 132 (100), 57 (23); HRMS: M+ found 309.1393, 
C16H23NO3S requires 309.1399. 
 
Ethyl 4-[(S)-tert-butylsulfinylimino]-4-phenylbutanoate (ent-2a): its physical and spectroscopic 
data are identical to the ones of iminoester 2a, except for the optical rotation: [α]D20 +6.1 (c 1.5, 
CH2Cl2). 
 
Ethyl 4-[(R)-tert-butylsulfinylimino]-4-(4-methoxyphenyl)butanoate (2b): yellow oil; Rf 0.47 
(hexane/ethyl acetate: 1/1); [α]D20 +32.0 (c 1.6, CH2Cl2); IR (neat) 3055, 1730, 1587, 1254, 1174, 1076 
cm-1; 1H NMR (300 MHz, CDCl3) δ 1.24 (3H, t, J = 7.1 Hz), 1.31 (9H, s), 2.53-2.84 (2H, m), 3.34-3.61 
(2H, m), 3.86 (3H, s), 4.13 (2H, q, J = 7.1 Hz), 6.93 (2H, d, J = 9.0 Hz), 7.70-8.01 (2H, br s); 13C NMR 
(75 MHz, CDCl3) δ 14.1, 22.5, 27.6, 33.1, 55.4, 57.4, 60.8, 113.9, 129.4, 129.7, 162.5, 172.0, 177.1; m/z 
(DIP) 339 (M+, <1%), 283 (41), 237 (28), 235 (55), 190 (17), 189 (30), 163 (23), 162 (100), 147 (18), 
134 (39), 133 (21), 57 (31); HRMS: M+ - C4H8 found 283.0888, C13H17NO4S requires 283.0878. 
 
Ethyl 4-[(S)-tert-butylsulfinylimino]-4-(4-methoxyphenyl)butanoate (ent-2b): its physical and 
spectroscopic data are identical to the ones of iminoester 2b, except for the optical rotation: [α]D20 −32.5 
(c 1.4, CH2Cl2). 
 
Ethyl 4-[(R)-tert-butylsulfinylimino]-4-(4-chlorophenyl)butanoate (2c): greenish oil; Rf 0.26 
(hexane/ethyl acetate: 3/1); [α]D20 +29.5 (c 1.1, CH2Cl2); IR (neat) 3064, 1732, 1601, 1585, 1179, 1090 
cm-1; 1H NMR (300 MHz, CDCl3) δ 1.24 (3H, t, J = 7.1 Hz), 1.32 (9H, s), 2.50-2.84 (2H, m), 3.15-3.74 
(2H, m), 4.13 (2H, q, J = 7.1 Hz), 7.40 (2H, d, J = 8.4 Hz), 7.63-7.90 (2H, br s); 13C NMR (75 MHz, 
CDCl3) δ 14.0, 22.6, 27.4, 32.7, 57.9, 60.8, 128.6, 128.8, 135.6, 137.9, 171.6, 176.3; m/z (DIP) 343 (M+, 
<1%), 289 (13), 287 (36), 243 (22), 241 (87), 239 (95), 168 (33), 166 (100), 137 (18), 57 (48); HRMS: 
M+ found 343.1018, C16H22ClNO3S requires 343.1009. 
 
Ethyl 4-[(S)-tert-butylsulfinylimino]-4-(4-chlorophenyl)butanoate (ent-2c): its physical and 
spectroscopic data are identical to the ones of iminoester 2c, except for the optical rotation: [α]D20 −29.0 
(c 1.0, CH2Cl2). 
 
Ethyl 4-[(R)-tert-butylsulfinylimino]-4-cyclopentylbutanoate (2d): an inseparable mixture of 
geometric isomers in ca. 3:1 ratio was obtained. The following characterization data are reported for the 
mixture of isomers with the relative integration for each signal: pale yellow oil; Rf 0.34 (hexane/ethyl 
acetate: 3/1); [α]D20 −63.0 (c 1.0, CH2Cl2); IR (neat) 1733, 1614, 1176, 1070 cm-1; 1H NMR (300 MHz, 
CDCl3) δ 1.16-1.29 (12.2H, m), 1.56-1.98 (8.2H, m), 2.50-3.05 (4.4H, m), 3.60-3.81 (0.6H, m), 4.01-
4.23 (2.0H, m); 13C NMR (75 MHz, CDCl3) δ 14.1, 21.8, 22.0, 22.3, 25.5, 25.86, 25.91, 29.4, 30.3, 
30.6, 30.7, 31.1, 31.5, 31.9, 45.9, 50.3, 55.9, 56.8, 60.4, 60.3, 171.9, 172.9, 188.7, 189.9; m/z (DIP) 301 
(M+, <1%), 273 (30), 227 (42), 225 (100), 179 (21), 151 (26), 138 (84), 109 (21), 57 (32); HRMS: M+ - 
C4H8 found 245.1086, C11H19NO3S requires 245.1086. 
 
Ethyl 4-[(S)-tert-butylsulfinylimino]-4-cyclopentylbutanoate (ent-2d): its physical and 
spectroscopic data are identical to the ones of iminoester 2d, except for the optical rotation: [α]D20 +62.0 
(c 0.9, CH2Cl2). 
 
Ethyl 4-[(R)-tert-butylsulfinylimino]-4-cyclohexylbutanoate (2e): an inseparable mixture of 
geometric isomers in ca. 3:1 ratio was obtained. The following characterization data are reported for the 
mixture of isomers with the relative integration for each signal: pale yellow oil; Rf 0.26 (hexane/ethyl 
acetate: 3/1); [α]D20 −65.0 (c 0.9, CH2Cl2); IR (neat) 1732, 1616, 1180, 1069 cm-1; 1H NMR (300 MHz, 
CDCl3) δ 0.93-1.54 (17.1H, m), 1.64-1.92 (5.1H, m), 2.21-2.30 (0.2H, m), 2.45-3.07 (3.7H, m), 3.25-
3.50 (0.6H, m), 4.04-4.20 (2.0H, m); 13C NMR (75 MHz, CDCl3) δ 14.1, 22.0, 22.4, 25.6, 25.8, 29.3, 
29.7, 30.2, 30.5, 30.7, 32.1, 45.5, 49.6, 56.0, 56.9, 60.4, 60.8, 172.0, 172.9, 188.7, 190.7; m/z (DIP) 315 
(M+, <1%), 287 (12), 259 (43), 239 (100), 193 (17), 152 (61), 57 (53); HRMS: M+ - C4H8 found 
259.1254, C12H21NO3S requires 259.1242. 
 
Ethyl 4-[(S)-tert-butylsulfinylimino]-4-cyclohexylbutanoate (ent-2e): its physical and spectroscopic 
data are identical to the ones of iminoester 2e, except for the optical rotation: [α]D20 +66.0 (c 1.1, 
CH2Cl2). 
 
Ethyl 4-[(R)-tert-butylsulfinylimino]-5-methylhexanoate (2f): pale yellow oil; Rf 0.38 (hexane/ethyl 
acetate: 7/3); [α]D20 −123.5 (c 1.9, CH2Cl2); IR (neat) 1733, 1618, 1173, 1072 cm-1; 1H NMR (300 MHz, 
CDCl3) δ 1.18 (6H, d, J = 6.9 Hz), 1.21 (9H, s), 1.25 (3H, t, J = 7.1 Hz), 2.51-3.05 (4H, m), 3.60-3.84 
(1H, m), 4.11 (2H, t, J = 7.1 Hz); 13C NMR (75 MHz, CDCl3) δ 14.1, 19.5, 20.3, 22.0, 29.1, 29.2, 34.6, 
56.0, 60.4, 172.8, 191.1; m/z (DIP) 275 (M+, <1%), 219 (14), 172 (11), 171 (100), 125 (27), 98 (38), 57 
(34); HRMS: M+ - C4H8 found 219.0917, C9H17NO3S requires 219.0929. 
 
Ethyl 4-[(S)-tert-butylsulfinylimino]-5-methylhexanoate (ent-2f): its physical and spectroscopic 
data are identical to the ones of iminoester 2f, except for the optical rotation: [α]D20 +124.0 (c 1.0, 
CH2Cl2). 
 
Ethyl 5-[(R)-tert-butylsulfinylimino]-5-phenylpentanoate (2g): yellow oil; Rf 0.35 (hexane/ethyl 
acetate: 3/1); [α]D20 −10.5 (c 1.1, CH2Cl2); IR (neat) 3050, 1729, 1591, 1181, 1068 cm-1; 1H NMR (300 
MHz, CDCl3) δ 1.26 (3H, t, J = 7.1 Hz), 1.33 (9H, s), 1.95-2.08 (2H, m), 2.46 (2H, t, J = 7.1 Hz), 3.11-
3.44 (2H, m), 4.14 (2H, q, J = 7.1 Hz), 7.39-7.52 (3H, m), 7.92 (2H, d, J = 6.5 Hz); 13C NMR (75 MHz, 
CDCl3) δ 14.2, 22.7, 23.8, 31.6, 33.7, 57.7, 60.4, 127.5, 128.6, 131.6, 137.6, 173.0, 178.8; m/z (DIP) 
323 (M+, <1%), 267 (15), 221 (21), 220 (14), 219 (94), 145 (18), 144 (19), 132 (100), 104 (19), 103 
(21), 77 (15), 57 (35); HRMS: M+ - C4H8 found 267.0936, C13H17NO3S requires 267.0929. 
 
Ethyl 5-[(S)-tert-butylsulfinylimino]-5-phenylpentanoate (ent-2g): its physical and spectroscopic 
data are identical to the ones of iminoester 2g, except for the optical rotation: [α]D20 +10.5 (c 1.0, 
CH2Cl2). 
 
Ethyl 5-[(R)-tert-butylsulfinylimino]-5-(4-methoxyphenyl)pentanoate (2h): yellow oil; Rf 0.26 
(hexane/ethyl acetate: 3/1); [α]D20 +19.0 (c 1.1, CH2Cl2); IR (neat) 3068, 1729, 1606, 1586, 1254, 1174, 
1067 cm-1; 1H NMR (400 MHz, CDCl3) δ 1.27 (3H, t, J = 7.1 Hz), 1.32 (9H, s), 1.95-2.04 (2H, m), 2.46 
(2H, t, J = 7.1 Hz), 3.03-3.40 (2H, m), 3.86 (3H, s), 4.15 (2H, q, J = 7.1 Hz), 6.93 (2H, d, J = 9.0 Hz), 
7.93 (2H, br d, apparent J = 7.8 Hz); 13C NMR (100 MHz, CDCl3) δ 14.2, 22.6, 24.0, 31.6, 33.7, 55.4, 
57.3, 60.4, 113.8, 129.5, 130.1, 162.5, 173.1, 178.3; m/z (DIP) 353 (M+, <1%), 297 (29), 249 (61), 175 
(30), 163 (20), 162 (100), 161 (20), 149 (18), 135 (34), 134 (21), 133 (18), 57 (20); HRMS: M+ - C4H8 
found 297.1040, C14H19NO4S requires 297.1035. 
 
Ethyl 5-[(S)-tert-butylsulfinylimino]-5-(4-methoxyphenyl)pentanoate (ent-2h): its physical and 
spectroscopic data are identical to the ones of iminoester 2h, except for the optical rotation: [α]D20 −19.0 
(c 1.1, CH2Cl2). 
 
Ethyl 5-[(R)-tert-butylsulfinylimino]-5-(2-naphthyl)pentanoate (2i): yellow oil; Rf 0.32 
(hexane/ethyl acetate: 4/1); [α]D20 +9.0 (c 3.0, CH2Cl2); IR (neat) 3058, 1729, 1610, 1588, 1186, 1068 
cm-1; 1H NMR (400 MHz, CDCl3) δ 1.26 (3H, t, J = 7.1 Hz), 1.37 (9H, s), 2.04-2.14 (2H, m), 2.50 (2H, 
t, J = 7.1 Hz), 3.14-3.39, 3.40-3.60 (1H each, 2 m), 4.16 (2H, q, J = 7.1 Hz), 7.51-7.58 (2H, m), 7.85 
(2H, d, J = 8.6 Hz), 7.95 (1H, d, J = 7.3 Hz), 8.05 (1H, d, J = 7.9 Hz), 8.41 (1H, s); 13C NMR (100 
MHz, CDCl3) δ 14.2, 22.7, 24.1, 31.6, 33.7, 57.7, 60.4, 124.1, 126.6, 127.4, 127.8, 128.2, 128.4, 129.3, 
132.7, 134.76, 134.83, 172.9, 178.6; m/z (DIP) 373 (M+, <1%), 317 (26), 269 (100), 195 (16), 182 (22), 
142 (14), 127 (29), 57 (43); HRMS: M+ - C4H8 found 317.1082, C17H19NO3S requires 317.1086. 
 
Ethyl 5-[(S)-tert-butylsulfinylimino]-5-(2-naphthyl)pentanoate (ent-2i): its physical and 
spectroscopic data are identical to the ones of iminoester 2i, except for the optical rotation: [α]D20 −8.5 
(c 2.0, CH2Cl2). 
 
Ethyl 5-[(R)-tert-butylsulfinylimino]-5-(2-thienyl)pentanoate (2j): yellow oil; Rf 0.38 (hexane/ethyl 
acetate: 3/1); [α]D20 +99.0 (c 1.0, CH2Cl2); IR (neat) 3075, 1729, 1572, 1182, 1071 cm-1; 1H NMR (400 
MHz, CDCl3) δ 1.27 (3H, t, J = 7.1 Hz), 1.31 (9H, s), 2.05-2.15 (2H, m), 2.47 (2H, t, J = 6.9 Hz), 3.07-
3.18, 3.22-3.32 (1H each, 2 m), 4.16 (2H, q, J = 7.1 Hz), 7.10 (1H, dd, J = 5.0, 3.8 Hz), 7.49 (1H, dd, J 
= 5.0, 0.9 Hz), 7.67 (1H, dd, J = 3.8, 0.9 Hz); 13C NMR (100 MHz, CDCl3) δ 14.2, 22.5, 24.4, 32.4, 
33.6, 57.8, 60.4, 128.1, 129.9, 132.1, 145.1, 173.0, 173.2; m/z (DIP) 329 (M+, <1%), 273 (33), 211 (11), 
198 (13), 197 (100), 156 (17), 124 (25), 57 (30); HRMS: M+ - C4H8 found 273.0499, C11H15NO3S2 
requires 273.0493. 
 
Ethyl 5-[(S)-tert-butylsulfinylimino]-5-(2-thienyl)pentanoate (ent-2j): its physical and 
spectroscopic data are identical to the ones of iminoester 2j, except for the optical rotation: [α]D20 
−100.0 (c 0.9, CH2Cl2). 
 
Ethyl 5-[(R)-tert-butylsulfinylimino]-6-methylheptanoate (2k): pale yellow oil; Rf 0.44 
(hexane/ethyl acetate: 3/2); [α]D20 −143.0 (c 2.2, CH2Cl2); IR (neat) 1733, 1620, 1182, 1071 cm-1; 1H 
NMR (300 MHz, CDCl3) δ 1.08-1.19 (6H, m), 1.24 (9H, s), 1.26 (3H, t, J = 7.1 Hz), 1.85-2.00 (2H, m), 
2.25-2.53 (3H, m), 2.57-2.88 (2H, m), 4.14 (2H, q, J = 7.1 Hz); 13C NMR (75 MHz, CDCl3) δ 14.2, 
20.1, 20.3, 22.3, 22.7, 33.9, 34.0, 39.1, 56.7, 60.3, 172.8, 190.8; m/z (DIP) 289 (M+, <1%), 186 (12), 
185 (100), 140 (15), 139 (42), 98 (68), 96 (21), 57 (54); HRMS: M+ - C4H8SO found 185.1415, 
C10H19NO2 requires 185.1416. 
 
Ethyl 5-[(S)-tert-butylsulfinylimino]-6-methylheptanoate (ent-2k): its physical and spectroscopic 
data are identical to the ones of iminoester 2k, except for the optical rotation: [α]D20 +142.0 (c 2.0, 
CH2Cl2). 
 
Ethyl 6-[(R)-tert-butylsulfinylimino]-6-phenylhexanoate (2l): yellow oil; Rf 0.32 (hexane/ethyl 
acetate: 3/1); [α]D20 −22.0 (c 0.9, CH2Cl2); IR (neat) 3061, 1731, 1593, 1179, 1071 cm-1; 1H NMR (400 
MHz, CDCl3) δ 1.23 (3H, t, J = 7.1 Hz), 1.33 (9H, s), 1.67-1.81 (4H, m), 2.34 (2H, t, J = 7.3 Hz), 3.07-
3.39 (2H, m), 4.10 (2H, q, J = 7.1 Hz), 7.40-7.50 (3H, m), 7.84 (2H, d, J = 6.7 Hz); 13C NMR (100 
MHz, CDCl3) δ 14.2, 22.7, 25.0, 28.1, 32.1, 33.8, 57.5, 60.3, 127.4, 128.6, 131.5, 137.7, 173.3, 179.4; 
m/z (DIP) 337 (M+, <1%), 281 (15), 234 (18), 233 (100), 171 (32), 144 (22), 143 (54), 132 (92), 104 
(25), 103 (21), 57 (41); HRMS: M+ - C4H8 found 281.1093, C14H19NO3S requires 281.1086. 
 
Ethyl 6-[(S)-tert-butylsulfinylimino]-6-phenylhexanoate (ent-2l): its physical and spectroscopic 
data are identical to the ones of iminoester 2l, except for the optical rotation: [α]D20 +22.5 (c 1.0, 
CH2Cl2). 
 
Asymmetric Transfer Hydrogenation of Iminoesters 2 and ent-2. General Procedure 
A mixture of [RuCl2(p-cymene)]2 (14 mg, 0.023 mmol), 2-amino-2-methylpropan-1-ol (4 mg, 0.045 
mmol), 4 Å molecular sieves (0.3 g) and anhydrous i-PrOH (1.5 mL) was heated up to 90 ºC (oil bath 
temperature) for 20 min. During this heating period, the initially orange reaction mixture turned into a 
dark red color. The reaction was then cooled to 50 ºC and a solution of the iminoester 2 or ent-2 (0.9 
mmol) in i-PrOH (6.3 mL) and t-BuOK (1.13 mL of a 0.1 M solution in i-PrOH, 0.113 mmol) were 
successively added. After completion of the reaction (monitored by TLC), the reaction mixture was 
passed through a small column of silica gel, the column was washed with ethyl acetate and the 
combined organic phases were evaporated to give a residue that was directly submitted to the 
desulfinylation step. 
For aliphatic iminoesters 2d-f, 2k, ent-2d-f and ent-2k, [RuCl2(p-cymene)]2 (28 mg, 0.045 mmol), 2-
amino-2-methylpropan-1-ol (8 mg, 0.090 mmol) and t-BuOK (2.25 mL of a 0.1 M solution in i-PrOH, 
0.225 mmol) were used. 
  
General Procedure for the Removal of the Sulfinyl Group. Isolation of Lactams 4a-4k and (ent-
4a)-(ent-4k) 
The crude mixture of the transfer hydrogenation reaction was dissolved in a 2 M solution of HCl in 
methanol (7 mL; prepared by dropwise addition of SOCl2 to methanol at 0 ºC) and stirred overnight at 
room temperature. Then, the solvent was evaporated, a 2 M aqueous HCl solution (10 mL) was added 
and the mixture was extracted with ethyl acetate (3 × 10 mL). The organic layers were discarded. The 
aqueous layer was basified with a buffer solution of NH3 (2 M) / NH4Cl (2 M) (10 mL) and a 2 M 
aqueous NaOH solution to ensure pH > 11. After ca. 10 minutes, the mixture was extracted with CH2Cl2 
(3 × 10 mL). The combined organic phases were dried (Na2SO4). After filtration and evaporation of the 
solvent, pure γ- and δ-lactams 4a-4k and (ent-4a)-(ent-4k) were obtained in the yields indicated in 
Scheme 4. The ee values were determined by HPLC using a chiral column (see the Supporting 
Information for details). The following pairs of enantiomeric lactams 4a and ent-4a,8a 4d and ent-4d,28 
4e and ent-4e,29 4f and ent-4f,30 4g and ent-4g,8a 4h and ent-4h,31 4k and ent-4k,32 were identified by 
comparison of their physical and spectroscopic data with the ones reported in the literature for one of 
the enantiomers. The corresponding physical and spectroscopic data for lactams 4b, ent-4b, 4c, ent-4c, 
4i, ent-4i, 4j and ent-4j follow. 
 
(R)-5-(4-Methoxyphenyl)pyrrolidin-2-one (4b): white solid; mp 92-94 ºC; Rf 0.28 (hexane/ethyl 
acetate: 1/3);  [α]D20 +40.5 (c 0.7, CH2Cl2, >99% ee); IR (neat) 3222, 3036, 1712, 1656, 1507, 1238 
cm-1; 1H NMR (400 MHz, CDCl3) δ 1.88-1.97, 2.47-2.56 (1H each, 2 m), 2.33-2.46 (2H, m), 3.79 (3H, 
s), 4.69 (1H, t, J = 7.1 Hz), 6.76 (1H, br s), 6.88, 7.21 (2H each, 2 d, J = 8.8 Hz each); 13C NMR (100 
MHz, CDCl3) δ 30.4, 31.3, 55.2, 57.6, 114.1, 126.8, 134.4, 159.1, 178.5; m/z 191 (M+, 100%), 190 (71), 
160 (15), 135 (18), 134 (50), 77 (27); HRMS: M+ found 191.0927, C11H13NO2 requires 191.0946. 
 
(S)-5-(4-Methoxyphenyl)pyrrolidin-2-one (ent-4b): its physical and spectroscopic data are identical 
to the ones of lactam 4b, except for the optical rotation: [α]D20 −41.0 (c 0.8, CH2Cl2, >99% ee). 
 
(R)-5-(4-Chlorophenyl)pyrrolidin-2-one (4c): white solid; mp 121-123 ºC; Rf 0.23 (hexane/ethyl 
acetate: 2/3); [α]D20 +46.0 (c 0.6, CH2Cl2, 97% ee); IR (neat) 3196, 3088, 1696, 1664, 1259, 1088 cm-1; 
1H NMR (400 MHz, CDCl3) δ 1.87-1.97, 2.52-2.63 (1H each, 2 m), 2.36-2.50 (2H, m), 4.74 (1H, t, J = 
7.1 Hz), 6.65 (1H, br s) 7.24, 7.34 (2H each, 2 d, J = 8.5 Hz each); 13C NMR (100 MHz, CDCl3) δ 30.2, 
31.3, 57.5, 127.0, 129.0, 133.6, 141.0, 178.6; m/z 197 (M+ + 2, 7%), 195 (M+, 21%), 160 (100), 140 
(42), 138 (31), 22 (84), 75 (12); HRMS: M+ found 195.0451, C10H10ClNO requires 195.0451. 
 
(S)-5-(4-Chlorophenyl)pyrrolidin-2-one (ent-4c): its physical and spectroscopic data are identical to 
the ones of lactam 4c, except for the optical rotation: [α]D20 −45.5 (c 0.7, CH2Cl2, 96% ee). 
 
(R)-6-(2-Naphthyl)piperidin-2-one (4i): white solid; mp 182-184 ºC; Rf 0.37 (hexane/ethyl acetate: 
2/3); [α]D20 +46.0 (c 0.6, CH2Cl2, 98% ee); IR (neat) 3267, 3050, 1658, 1622, 1467, 1368 cm-1; 1H NMR 
(300 MHz, CDCl3) δ 1.62-1.98 (3H, m), 2.10-2.23 (1H, m), 2.38-2.57 (2H, m), 4.71 (1H, dd, J = 8.0, 
4.5 Hz), 6.12 (1H, br s), 7.38 (1H, dd, J = 8.5, 1.7 Hz), 7.45-7.53 (2H, m), 7.74 (1H, s), 7.78-7.89 (3H, 
m); 13C NMR (75 MHz, CDCl3) δ 19.5, 31.3, 31.9, 57.7, 124.0, 124.8, 126.1, 126.5, 127.6, 127.8, 128.7, 
132.9, 133.2, 139.8, 172.4; m/z 225 (M+, 100%), 224 (39), 196 (24), 168 (21), 155 (56), 154 (64), 129 
(19), 69 (17); HRMS: M+ found 225.1180, C15H15NO requires 225.1154. 
 
(S)-6-(2-Naphthyl)piperidin-2-one (ent-4i): its physical and spectroscopic data are identical to the 
ones of lactam 4i, except for the optical rotation: [α]D20 −44.0 (c 0.7, CH2Cl2, 97% ee). 
 
(R)-6-(2-Thienyl)piperidin-2-one (4j): white solid; mp 97-98 ºC; Rf 0.26 (hexane/ethyl acetate: 1/3); 
[α]D20 +63.0 (c 0.7, CH2Cl2, 98% ee); IR (neat) 3266, 3080, 1653, 1619, 1480 cm-1; 1H NMR (300 MHz, 
CDCl3) δ 1.70-1.86 (2H, m), 1.89-1.99, 2.12-2.24 (1H each, 2 m), 2.34-2.51 (2H, m), 4.85 (1H, dd, J = 
7.0, 5.0 Hz), 6.31 (1H, br s), 6.94-7.01 (2H, m), 7.25 (1H, dd, J = 4.5, 1.8 Hz); 13C NMR (75 MHz, 
CDCl3) δ 19.4, 31.1, 32.2, 53.2, 124.2, 124.7, 126.8, 146.3, 171.7; m/z 181 (M+, 100%), 180 (21), 152 
(30), 112 (35), 110 (38), 69 (17); HRMS: M+ found 181.0566, C9H11NOS requires 181.0561. 
 
(S)-6-(2-Thienyl)piperidin-2-one (ent-4j): its physical and spectroscopic data are identical to the 
ones of lactam 4j, except for the optical rotation: [α]D20 −64.0 (c 0.7, CH2Cl2, 99% ee). 
 
Desulfinylation of the ATH Product from Iminoesters 2l and ent-2l. Isolation of ε-Lactams 4l 
and ent-4l 
The crude mixture of the transfer hydrogenation of iminoester 2l or ent-2l was dissolved in dry MeOH 
(2 mL) and a 2 M solution of HCl in Et2O (9 mL, 18 mmol) was added dropwise at 0 ºC. The reaction 
was stirred overnight at room temperature. Then, a 1.5 M solution of MeONa in MeOH [freshly 
prepared by adding carefully sodium (690 mg, 30 mmol) to MeOH (20 mL) in an open flask at room 
temperature] was added at 0 ºC and the reaction was stirred overnight at room temperature. Then, 
solvents were evaporated, a 0.5 M aqueous NaOH solution (10 mL) was added and the mixture was 
extracted with Et2O (3 × 10 mL). The combined organic phases were dried (Na2SO4). After filtration 
and evaporation of the solvent, the residue was purified by column chromatography (silica gel, 
hexane/ethyl acetate) to afford ε-lactams 4l and ent-4l in the yields indicated in Scheme 4. The ee values 
were determined by HPLC using a ChiralCel OD-H column (see the Supporting Information for 
details). The corresponding physical and spectroscopic data for compounds 4l and ent-4l follow. 
 
(R)-7-phenylazepan-2-one (4l):33 white solid; mp 136 ºC; Rf 0.31 (hexane/ethyl acetate: 2/3); [α]D20 
+44.0 (c 0.5, CHCl3, 98% ee); IR (neat) 3208, 3067, 1647, 1406 cm-1; 1H NMR (300 MHz, CDCl3) δ 
1.66-1.79 (2H, m), 1.87-2.15 (4H, m), 2.51-2.66 (2H, m), 4.47 (1H, ddd, J = 9.3, 4.1, 2.0 Hz), 5.68 (1H, 
br s), 7.30-7.42 (5H, m); 13C NMR (75 MHz, CDCl3) δ 23.1, 29.9, 37.1, 37.2, 58.7, 126.2, 128.2, 129.2, 
142.4, 177.2; m/z 189 (M+, 32%), 161 (42), 106 (100), 104 (33), 91 (18), 79 (19). 
 
(S)-7-phenylazepan-2-one (ent-4l):33 its physical and spectroscopic data are identical to the ones of 
lactam 4l, except for the optical rotation: [α]D20 −44.5 (c 0.6, CHCl3, 98% ee). 
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